DK158725C - N-phenyl-oxamsyrederivater og farmaceutiske praeparater indeholdende disse - Google Patents

N-phenyl-oxamsyrederivater og farmaceutiske praeparater indeholdende disse

Info

Publication number
DK158725C
DK158725C DK418484A DK418484A DK158725C DK 158725 C DK158725 C DK 158725C DK 418484 A DK418484 A DK 418484A DK 418484 A DK418484 A DK 418484A DK 158725 C DK158725 C DK 158725C
Authority
DK
Denmark
Prior art keywords
carbon atoms
alkoxy
hydrogen
amino
acid derivatives
Prior art date
Application number
DK418484A
Other languages
English (en)
Other versions
DK418484D0 (da
DK158725B (da
DK418484A (da
Inventor
Karl G Grozinger
James T Oliver
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of DK418484D0 publication Critical patent/DK418484D0/da
Publication of DK418484A publication Critical patent/DK418484A/da
Publication of DK158725B publication Critical patent/DK158725B/da
Application granted granted Critical
Publication of DK158725C publication Critical patent/DK158725C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/16Halogen atoms; Nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK418484A 1983-09-01 1984-08-31 N-phenyl-oxamsyrederivater og farmaceutiske praeparater indeholdende disse DK158725C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52852283A 1983-09-01 1983-09-01
US52852283 1983-09-01

Publications (4)

Publication Number Publication Date
DK418484D0 DK418484D0 (da) 1984-08-31
DK418484A DK418484A (da) 1985-03-02
DK158725B DK158725B (da) 1990-07-09
DK158725C true DK158725C (da) 1990-12-10

Family

ID=24106021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK418484A DK158725C (da) 1983-09-01 1984-08-31 N-phenyl-oxamsyrederivater og farmaceutiske praeparater indeholdende disse

Country Status (22)

Country Link
EP (1) EP0137979B1 (da)
JP (1) JPS60142968A (da)
KR (1) KR900001217B1 (da)
AT (1) ATE38224T1 (da)
AU (1) AU569541B2 (da)
CA (1) CA1219873A (da)
CS (1) CS241100B2 (da)
DD (1) DD227964A5 (da)
DE (1) DE3474817D1 (da)
DK (1) DK158725C (da)
ES (1) ES8505934A1 (da)
FI (1) FI84477C (da)
GR (1) GR80245B (da)
HU (1) HU192576B (da)
IE (1) IE59035B1 (da)
IL (1) IL72833A (da)
NO (1) NO843477L (da)
NZ (1) NZ209405A (da)
PH (1) PH22753A (da)
PT (1) PT79163B (da)
SU (1) SU1342410A3 (da)
ZA (1) ZA846826B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62145049A (ja) * 1985-12-18 1987-06-29 Mitsubishi Chem Ind Ltd アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
WO1992000963A1 (en) * 1990-07-12 1992-01-23 Yoshitomi Pharmaceutical Industries, Ltd. Styryl compounds and use thereof as medicine
JP2832923B2 (ja) * 1990-07-13 1998-12-09 吉富製薬株式会社 スチリル化合物およびその医薬用途
WO1999035140A1 (en) * 1998-01-12 1999-07-15 Novartis Ag PYRIDINYLPYRIMIDINE AMINES AS IMMUNOGLOBULINE E (IgE) SYNTHESIS INHIBITORS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1259685A (en) * 1969-04-03 1972-01-12 Soc D Etudes Prod Chimique Amino-pyrimidine derivatives
US3993679A (en) * 1972-12-20 1976-11-23 The Upjohn Company Cyano phenylene dioxamic molecules
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US3953468A (en) * 1974-03-15 1976-04-27 The Upjohn Company 3-Cyano thiophen-2-yl oxamic acid and derivatives
CA1066714A (en) * 1974-06-10 1979-11-20 John B. Wright Pharmaceutical n-phenyloxamic acid derivatives
DE2828091A1 (de) * 1978-06-27 1980-01-10 Boehringer Sohn Ingelheim 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester
JPS5761028A (en) * 1980-09-30 1982-04-13 Sanyo Chem Ind Ltd Formation of heat-insulating primer layer and heat-insulating structure

Also Published As

Publication number Publication date
EP0137979A1 (en) 1985-04-24
FI84477B (fi) 1991-08-30
PH22753A (en) 1988-11-28
FI843417A0 (fi) 1984-08-30
AU569541B2 (en) 1988-02-04
IE842237L (en) 1985-03-01
ATE38224T1 (de) 1988-11-15
AU3260084A (en) 1985-03-07
HU192576B (en) 1987-06-29
DK418484D0 (da) 1984-08-31
NZ209405A (en) 1987-05-29
KR900001217B1 (ko) 1990-02-28
KR850002258A (ko) 1985-05-10
DK158725B (da) 1990-07-09
SU1342410A3 (ru) 1987-09-30
HUT37129A (en) 1985-11-28
IL72833A0 (en) 1984-11-30
CS654584A2 (en) 1985-07-16
CA1219873A (en) 1987-03-31
DK418484A (da) 1985-03-02
ZA846826B (en) 1986-04-30
PT79163B (en) 1986-11-18
FI84477C (fi) 1991-12-10
NO843477L (no) 1985-03-04
CS241100B2 (en) 1986-03-13
IE59035B1 (en) 1993-12-15
IL72833A (en) 1987-09-16
DE3474817D1 (en) 1988-12-01
JPS60142968A (ja) 1985-07-29
FI843417A (fi) 1985-03-02
ES535572A0 (es) 1985-06-16
PT79163A (en) 1984-09-01
GR80245B (en) 1985-01-03
ES8505934A1 (es) 1985-06-16
DD227964A5 (de) 1985-10-02
EP0137979B1 (en) 1988-10-26

Similar Documents

Publication Publication Date Title
DE19775082I2 (de) Indol-Derivate.
DK391289A (da) Indolderivater
NO965305L (no) Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler
HUT40790A (en) Process for producing 2-/4-benzoyl-1-piperidinyl/-1-phenyl-alkanol derivatives and pharmaceutical compositions containing them
DK616388A (da) Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
DK158725C (da) N-phenyl-oxamsyrederivater og farmaceutiske praeparater indeholdende disse
FI881104A (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
ES8801205A1 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
SE8703494L (sv) Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat

Legal Events

Date Code Title Description
PBP Patent lapsed